Abstract | OBJECTIVES: MATERIAL AND METHODS: RESULTS: Fifteen patients (42.9%) in group D, 21 (60% in group M and 19 (54.3%) in group P experienced nausea during the 24 h after surgery, with no significant differences. However, the incidence of vomiting was significantly lower in group D, with 7 patients (20%) vomiting in group D versus 11 patients (31.43%) in group M and 17 (50%) in group P. Side effects were mild and required no treatment. CONCLUSIONS:
|
Authors | F J Delás Ramírez, J Ros Mora, M Ledesma Vázquez, M López Rodríguez, M A Fernández Martínez, A Villalonga Morales |
Journal | Revista espanola de anestesiologia y reanimacion
(Rev Esp Anestesiol Reanim)
Vol. 48
Issue 2
Pg. 65-8
(Feb 2001)
ISSN: 0034-9356 [Print] Spain |
Vernacular Title | Prevención de las náuseas y vómitos postoperatorios en cirugía ginecológica mediante tres dosis fijas de metoclopramida, droperidol o placebo. |
PMID | 11257953
(Publication Type: Clinical Trial, English Abstract, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Antiemetics
- Metoclopramide
- Droperidol
|
Topics |
- Adult
- Aged
- Antiemetics
(administration & dosage)
- Double-Blind Method
- Droperidol
(administration & dosage)
- Drug Administration Schedule
- Female
- Gynecologic Surgical Procedures
- Humans
- Metoclopramide
(administration & dosage)
- Middle Aged
- Postoperative Nausea and Vomiting
(prevention & control)
- Preanesthetic Medication
- Prospective Studies
|